{
  "main_header": {
    "sid": 1003095,
    "name": "Deccan Healthcar",
    "stock_name": "Deccan Healthcar",
    "full_name": "Deccan Health Care Ltd",
    "name_url": "stocks-analysis/deccan-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.99",
    "chg": -0.01,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "14.00",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542248,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE452W01019",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 12571,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/deccan-healthcar-1003095-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Deccan Healthcar?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-deccan-healthcar-3703886",
        "imagepath": "",
        "date": "2025-11-15 00:17:14",
        "description": "Answer:\nThe historical performance of Deccan Healthcar shows a fluctuating trend in key financial metrics over the past several years.\n\nBreakdown:\nDeccan Healthcar's net sales have shown a consistent increase from INR 33.17 crore in March 2022 to INR 75.06 crore in March 2025. However, the total operating income has mirrored this growth, reaching INR 75.06 crore in March 2025. The raw material cost has also risen significantly, from INR 3.98 crore in March 2022 to INR 40.89 crore in March 2025, indicating increased operational expenses. The total expenditure, excluding depreciation, has escalated from INR 27.83 crore in March 2022 to INR 71.91 crore in March 2025. Consequently, the operating profit (PBDIT) has seen a decline from INR 5.34 crore in March 2022 to INR 3.16 crore in March 2025. Profit before tax has also decreased from INR 0.54 crore in March 2022 to INR 1.63 crore in March 2025, while profit a..."
      },
      {
        "title": "When is the next results date for Deccan Healthcar?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-deccan-healthcar-3691209",
        "imagepath": "",
        "date": "2025-11-11 23:19:59",
        "description": "Deccan Healthcar is scheduled to declare its results on 14 November 2025...."
      },
      {
        "title": "Why is Deccan Healthcar falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-deccan-healthcar-fallingrising-3681539",
        "imagepath": "",
        "date": "2025-11-07 23:50:12",
        "description": "As of 07-Nov, Deccan Health Care Ltd's stock price is currently at 16.35, reflecting a decline of 0.6, or 3.54%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in an 8.91% decrease over the past week. Additionally, the stock's performance has been weak over longer periods, with a year-to-date return of -44.10% and a one-year return of -41.61%. Despite some positive indicators such as a high inventory turnover ratio and net sales, the stock's overall performance is hampered by weak long-term fundamentals, including a low return on equity and poor debt servicing ability.\n\nIn the broader market context, Deccan Health Care's recent performance contrasts sharply with the benchmark, as the Sensex has only declined by 0.86% over the past week. This significant underperformance highlights the stock's struggles, particularly given its consistent negative returns ove..."
      }
    ],
    "total": 114,
    "sid": "1003095",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/deccan-health-care-1003095"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "21-Jan-2026",
      "details": "Certificate under Reg 74(5) for Quarter ended Dec 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "10-Jan-2026",
      "details": "Resignation of CS and compliance officer.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Dear Sir/Madam Pursuant to the Code of Conduct for Regulating Monitoring & Reporting Trading by Insiders of the Company under SEBI (Prohibition of Insider Trading) Regulations 2015 we would like to inform you that the trading window for the purpose of trading in shared of the Company by its Designated Persons and its Immediate relatives shall remain closed from 01st January 2026 till 48 hours after the announcement of the unaudited financial results for the quarter ended 31st December 2025. The date of the board meeting for the consideration and declaration of unaudited financial results for the quarter ended 31st December 2025 will be intimated in due course. It is the responsibility of each insider and insiders immediate relatives to ensure compliance with the insider code of the company and shall not deal in the companys securities during the above period of trading window closure Thank you Yours Sincerely",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Deccan Healthcar?

2025-11-15 00:17:14

Answer: The historical performance of Deccan Healthcar shows a fluctuating trend in key financial metrics over the past several years. Breakdown: Deccan Healthcar's net sales have shown a consistent increase from INR 33.17 crore in March 2022 to INR 75.06 crore in March 2025. However, the total operating income has mirrored this growth, reaching INR 75.06 crore in March 2025. The raw material cost has also risen significantly, from INR 3.98 crore in March 2022 to INR 40.89 crore in March 2025, indicating increased operational expenses. The total expenditure, excluding depreciation, has escalated from INR 27.83 crore in March 2022 to INR 71.91 crore in March 2025. Consequently, the operating profit (PBDIT) has seen a decline from INR 5.34 crore in March 2022 to INR 3.16 crore in March 2025. Profit before tax has also decreased from INR 0.54 crore in March 2022 to INR 1.63 crore in March 2025, while profit a...

Read More

When is the next results date for Deccan Healthcar?

2025-11-11 23:19:59

Deccan Healthcar is scheduled to declare its results on 14 November 2025....

Read More

Why is Deccan Healthcar falling/rising?

2025-11-07 23:50:12

As of 07-Nov, Deccan Health Care Ltd's stock price is currently at 16.35, reflecting a decline of 0.6, or 3.54%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in an 8.91% decrease over the past week. Additionally, the stock's performance has been weak over longer periods, with a year-to-date return of -44.10% and a one-year return of -41.61%. Despite some positive indicators such as a high inventory turnover ratio and net sales, the stock's overall performance is hampered by weak long-term fundamentals, including a low return on equity and poor debt servicing ability. In the broader market context, Deccan Health Care's recent performance contrasts sharply with the benchmark, as the Sensex has only declined by 0.86% over the past week. This significant underperformance highlights the stock's struggles, particularly given its consistent negative returns ove...

Read More

View All News